Robert M. Davis
Executive Vice President and Chief Financial Offic
business and development
C.R. Bard,Inc.
Portugal
Biography
Mr. Davis is currently the Executive Vice President and Chief Financial Officer of Merck & Co., Inc. (“Merck”). Mr. Davis served as Executive Vice President and Chief Financial Officer of Merck since April 2014. Prior to that, Mr. Davis served as Corporate Vice President and President of Baxter Renal Division from June 2010 to October 2010 and Corporate Vice President and President of Baxter Medical Products from October 2010 to April 2014, having been Corporate Vice President and Chief Financial Officer of Baxter Healthcare from May 2006 to June 2010, and Treasurer of Baxter Healthcare from November 2004 to May 2006. He also served as Director of Corporate Financial Planning of Eli Lilly and Company from 2002 to 2004, and as Assistant Treasurer and various financial positions at Eli Lilly and Company from 1990 to 2002. Mr. Davis has been a director of C. R. Bard, Inc. since October 2015 and is a member of the Audit Committee, the Finance Committee and the Science & Technology Committee.
Research Interest
medical product development
